News
StockStory.org on MSN19h
LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price PressuresGlobal pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.
Bristol Myers CEO Christopher Boerner advocates global cost-sharing for drug R&D and criticizes PBMs. Read nore here.
Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...
Because the drug changes the colour of urine, patients would know if they were in the active arm of the study if a regular placebo was used. As a result, TauRx opted to use methylthioninium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results